LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

LLY

1,041.67

-0.67%↓

JNJ

203.38

+0.19%↑

ABBV

229.55

-1.49%↓

UNH

311.75

+0.84%↑

AZN

88.67

-0.36%↓

Search

Abbott Laboratories

Cerrado

SectorSalud

124 -1.74

Resumen

Variación precio

24h

Actual

Mínimo

121.97

Máximo

126.13

Métricas clave

By Trading Economics

Ingresos

-135M

1.6B

Ventas

227M

11B

P/B

Media del Sector

16.335

106.172

BPA

1.3

Rentabilidad por dividendo

1.81

Margen de beneficio

14.46

Empleados

114,000

EBITDA

-824M

2.2B

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+16.63% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.81%

2.31%

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-2.3B

226B

Apertura anterior

125.74

Cierre anterior

124

Noticias sobre sentimiento de mercado

By Acuity

43%

57%

160 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

Abbott Laboratories Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

20 nov 2025, 13:14 UTC

Adquisiciones, fusiones, absorciones

Correction to Abbott to Acquire Exact Sciences for $21 Billion Article

20 nov 2025, 13:11 UTC

Adquisiciones, fusiones, absorciones

Abbott to Acquire Exact Sciences for $21 Billion -- Update

20 nov 2025, 12:55 UTC

Adquisiciones, fusiones, absorciones

Abbott to Acquire Exact Sciences for $21 Billion

20 nov 2025, 21:23 UTC

Ganancias
Adquisiciones, fusiones, absorciones

These Stocks Moved the Most Today: Nvidia, Exact Sciences, Walmart, AMD, Alphabet, Palo Alto Networks, and More -- Barrons.com

20 nov 2025, 16:51 UTC

Adquisiciones, fusiones, absorciones

Abbott Laboratories Will Buy Cologuard Maker Exact Sciences for $21 Billion -- Barrons.com

20 nov 2025, 15:08 UTC

Adquisiciones, fusiones, absorciones

Abbott to Acquire Exact Sciences for $21 Billion -- 4th Update

20 nov 2025, 14:39 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Abbott and Exact Sciences Should Make a Good Fit -- Market Talk

20 nov 2025, 14:30 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Exact Sciences Should Give Abbott's Diagnostics Business a Needed Boost -- Market Talk

20 nov 2025, 13:54 UTC

Adquisiciones, fusiones, absorciones

These Stocks Are Moving the Most Today: Nvidia, Exact Sciences, Walmart, AMD, Palo Alto Networks, Alphabet, and More -- Barrons.com

20 nov 2025, 13:51 UTC

Adquisiciones, fusiones, absorciones

Abbott to Acquire Exact Sciences for $21 Billion -- 3rd Update

20 nov 2025, 13:25 UTC

Adquisiciones, fusiones, absorciones

Abbott to Acquire Exact Sciences for $21 Billion -- 2nd Update

20 nov 2025, 13:24 UTC

Adquisiciones, fusiones, absorciones

Exact Sciences Stock Soars. Abbott Is Buying It in Deal Valued at $21 Billion. -- Barrons.com

20 nov 2025, 12:59 UTC

Adquisiciones, fusiones, absorciones

Correction to Abbott to Acquire Exact Sciences for $21B Article

20 nov 2025, 12:58 UTC

Adquisiciones, fusiones, absorciones

Exact Sciences Stock Soars. Abbott Is Buying It in Deal Valued at $21 Billion. -- Barrons.com

20 nov 2025, 12:56 UTC

Adquisiciones, fusiones, absorciones

Abbott to Acquire Exact Sciences for $21B -- Update

20 nov 2025, 12:54 UTC

Adquisiciones, fusiones, absorciones

Abbott Labs: Expect to Maintain Investment-Grade Credit Rating >ABT EXAS

20 nov 2025, 12:53 UTC

Adquisiciones, fusiones, absorciones

Abbott Labs to Fund Exact Sciences Deal With Cash on Hand, Debt Financing >ABT EXAS

20 nov 2025, 12:53 UTC

Adquisiciones, fusiones, absorciones

Abbott Labs Sees Exact Sciences Deal Adding to Adjusted EPS in 2028, Beyond >ABT EXAS

20 nov 2025, 12:53 UTC

Adquisiciones, fusiones, absorciones

Abbott Labs Sees Exact Sciences Deal Cutting Adjusted EPS by 20c in 2026, 16c in 2027 >ABT EXAS

20 nov 2025, 12:52 UTC

Adquisiciones, fusiones, absorciones

Abbott Labs Sees at Least $100 Million Annual Pretax Synergies From Exact Sciences Deal by 2028 >ABT EXAS

20 nov 2025, 12:46 UTC

Adquisiciones, fusiones, absorciones

Exact Sciences Stock Soars. Abbott Is Buying It in Deal Valued at $21 Billion. -- Barrons.com

20 nov 2025, 12:40 UTC

Adquisiciones, fusiones, absorciones

Abbott to Acquire Exact Sciences for $21B

20 nov 2025, 12:33 UTC

Adquisiciones, fusiones, absorciones

Abbott Labs: Exact Sciences Deal Has Enterprise Value of About $23 Billion >ABT EXAS

20 nov 2025, 12:33 UTC

Adquisiciones, fusiones, absorciones

Exact Sciences to Be Acquired for $105/Share; Closed Wednesday at $86.18 >ABT EXAS

20 nov 2025, 12:32 UTC

Adquisiciones, fusiones, absorciones

Abbott Labs Sees Acquisition Immediately Adding to Revenue Growth, Gross Margin >ABT EXAS

20 nov 2025, 12:31 UTC

Adquisiciones, fusiones, absorciones

Abbott Labs: Exact Sciences Deal Has Total Equity Value of About $21 Billion >ABT EXAS

20 nov 2025, 12:30 UTC

Adquisiciones, fusiones, absorciones

Abbott to Buy Exact Sciences for $105/Share >ABT EXAS

20 nov 2025, 12:30 UTC

Adquisiciones, fusiones, absorciones

Abbott To Acquire Exact Sciences, A Leader In Large And Fast-growing Cancer Screening And Precision Oncology Diagnostics Segments >ABT

19 nov 2025, 21:27 UTC

Adquisiciones, fusiones, absorciones

Exact Sciences Stock Jumps on Reported Deal Interest from Abbott Laboratories -- Barrons.com

30 oct 2025, 12:38 UTC

Ganancias

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

Comparación entre iguales

Cambio de precio

Abbott Laboratories Esperado

Precio Objetivo

By TipRanks

16.63% repunte

Estimación a 12 meses

Media 147.13 USD  16.63%

Máximo 162 USD

Mínimo 136 USD

De acuerdo con 18 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Abbott Laboratories Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

18 ratings

16

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

132.82 / 134.43Soporte y Resistencia

Corto Plazo

Weak Bullish Evidence

Medio plazo

Neutral Evidence

Largo Plazo

Bullish Evidence

Sentimiento

By Acuity

160 / 374 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
help-icon Live chat